Note 8 - Revenue Recognition (Tables)

6 Months Ended

Jun. 30, 2026

Notes Tables

Disaggregation of Revenue [Table Text Block]

		Three months ended								Six months ended
		June 30,								June 30,
		2026				2025				2026				2025

Pharmaceuticals		$	1,468,342			$	1,451,679			$	2,912,310			$	2,620,137
Cosmetic & Sexual Wellness ingredients			1,286,699				896,549				2,131,963				1,595,546
Medical lubricants			353,226				489,997				936,216				1,103,669
Total Net Sales		$	3,108,267			$	2,838,225			$	5,980,489			$	5,319,352

Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue [Table Text Block]

		Three months ended								Six months ended
		June 30,								June 30,
		2026				2025				2026				2025
United States*		$	2,573,234			$	2,346,526			$	4,808,126			$	4,103,793
Other countries			535,033				491,699				1,172,363				1,215,559
Total Sales		$	3,108,267			$	2,838,225			$	5,980,489			$	5,319,352